Adjuvant therapy for early breast cancer: a time to refine.
Open Access
- 19 November 1997
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 89 (22) , 1652-1654
- https://doi.org/10.1093/jnci/89.22.1652
Abstract
Adjuvant endocrine therapy and chemotherapy are now being used extensively to treat primary breast cancer and are probably beginning to have an impact on national mortality data in the U.K. ( 1 , 2 ). The main difficulty at present is identifying those patients who may require such treatment.Keywords
This publication has 11 references indexed in Scilit:
- Tamoxifen and Chemotherapy for Lymph Node-Negative, Estrogen Receptor-Positive Breast CancerJNCI Journal of the National Cancer Institute, 1997
- Preoperative chemotherapy induces apoptosis in early breast cancerThe Lancet, 1997
- Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screeningBMJ, 1995
- Sudden fall in breast cancer death rates in England and WalesThe Lancet, 1995
- Primary Chemotherapy To Avoid Mastectomy in Tumors With Diameters of Three Centimeters or MoreJNCI Journal of the National Cancer Institute, 1990
- Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public.BMJ, 1990
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast CancerNew England Journal of Medicine, 1988
- Adjuvant Chemotherapy for Breast CancerPublished by American Medical Association (AMA) ,1985
- Ten-Year Results of a Randomized Clinical Trial Comparing Radical Mastectomy and Total Mastectomy with or without RadiationNew England Journal of Medicine, 1985